These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35038424)

  • 41. Successful Aspects of the Coadministration of Sterol 14α-Demethylase Inhibitor VFV and Benznidazole in Experimental Mouse Models of Chagas Disease Caused by the Drug-Resistant Strain of Trypanosoma cruzi.
    Guedes-da-Silva FH; Batista DDGJ; Da Silva CF; Pavão BP; Batista MM; Moreira OC; Souza LRQ; Britto C; Rachakonda G; Villalta F; Lepesheva GI; Soeiro MNC
    ACS Infect Dis; 2019 Mar; 5(3):365-371. PubMed ID: 30625275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The in vivo trypanocidal effect of the diterpene 5-epi-icetexone obtained from Salvia gilliesii.
    Lozano E; Strauss M; Spina R; Cifuente D; Tonn C; Rivarola HW; Sosa MA
    Parasitol Int; 2016 Feb; 65(1):23-26. PubMed ID: 26341064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.
    Khare S; Liu X; Stinson M; Rivera I; Groessl T; Tuntland T; Yeh V; Wen B; Molteni V; Glynne R; Supek F
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6385-94. PubMed ID: 26239982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trypanosoma cruzi infection and benznidazole therapy independently stimulate oxidative status and structural pathological remodeling of the liver tissue in mice.
    Novaes RD; Santos EC; Cupertino MC; Bastos DS; Oliveira JM; Carvalho TV; Neves MM; Oliveira LL; Talvani A
    Parasitol Res; 2015 Aug; 114(8):2873-81. PubMed ID: 25912691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.
    Solana ME; Alba Soto CD; Fernández MC; Poncini CV; Postan M; González Cappa SM
    Parasitology; 2009 May; 136(6):627-39. PubMed ID: 19366478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.
    Oliveira-Silva JC; Machado-de-Assis GF; Oliveira MT; Paiva NC; Araújo MS; Carneiro CM; Martins-Filho OA; Martins HR; Lana Md
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):86-94. PubMed ID: 25742267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy.
    Silva Grijó Farani P; Iandra da Silva Ferreira B; Begum K; Vilar-Pereira G; Pereira IR; Fernández-Figueroa EA; Cardenas-Ovando RA; Almeida IC; Roy S; Lannes-Vieira J; Moreira OC
    PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011223. PubMed ID: 36972298
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absence of CD4+ T lymphocytes, CD8+ T lymphocytes, or B lymphocytes has different effects on the efficacy of posaconazole and benznidazole in treatment of experimental acute Trypanosoma cruzi infection.
    Ferraz ML; Gazzinelli RT; Alves RO; Urbina JA; Romanha AJ
    Antimicrob Agents Chemother; 2009 Jan; 53(1):174-9. PubMed ID: 19001113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Miltefosine and Benznidazole Combination Improve Anti-
    Gulin JEN; Bisio MMC; Rocco D; Altcheh J; Solana ME; García-Bournissen F
    Front Cell Infect Microbiol; 2022; 12():855119. PubMed ID: 35865815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of chagas disease.
    Sesti-Costa R; Carneiro ZA; Silva MC; Santos M; Silva GK; Milanezi C; da Silva RS; Silva JS
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3207. PubMed ID: 25275456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi
    Pandey RP; Nascimento MS; Franco CH; Bortoluci K; Silva MN; Zingales B; Gibaldi D; Castaño Barrios L; Lannes-Vieira J; Cariste LM; Vasconcelos JR; Moraes CB; Freitas-Junior LH; Kalil J; Alcântara L; Cunha-Neto E
    Antimicrob Agents Chemother; 2022 Nov; 66(11):e0028422. PubMed ID: 36314800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
    Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination therapy with benznidazole and doxycycline shows no additive effect to monotherapy with benznidazole in mice infected with the VL-10 strain of the Trypanosoma cruzi.
    Carneiro ACA; Costa GP; Ferreira CS; Ramos IPR; Sarandy MM; Leite ALJ; Menezes APJ; Silva BM; Nogueira KOPC; Carvalho ACC; Gonçalves RV; Talvani A
    Int J Cardiol; 2020 Jan; 299():243-248. PubMed ID: 31353153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.
    Bustamante JM; Craft JM; Crowe BD; Ketchie SA; Tarleton RL
    J Infect Dis; 2014 Jan; 209(1):150-62. PubMed ID: 23945371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
    Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
    Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II).
    Campos RF; Guerreiro ML; Sobral Kde S; Lima Rde C; Andrade SG
    Rev Soc Bras Med Trop; 2005; 38(2):142-6. PubMed ID: 15821788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myocardial scars correlate with eletrocardiographic changes in chronic Trypanosoma cruzi infection for dogs treated with Benznidazole.
    Caldas IS; da Matta Guedes PM; dos Santos FM; de Figueiredo Diniz L; Martins TA; da Silva do Nascimento AF; Azevedo MA; de Lima WG; Neto RM; Torres RM; Talvani A; Bahia MT
    Trop Med Int Health; 2013 Jan; 18(1):75-84. PubMed ID: 23107306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Essential oils from Syzygium aromaticum and Zingiber officinale, administered alone or in combination with benznidazole, reduce the parasite load in mice orally inoculated with Trypanosoma cruzi II.
    Sarto MPM; Lucas da Silva HF; de Souza Fernandes N; de Abreu AP; Zanusso Junior G; de Ornelas Toledo MJ
    BMC Complement Med Ther; 2021 Feb; 21(1):77. PubMed ID: 33632196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myocarditis in different experimental models infected by Trypanosoma cruzi is correlated with the production of IgG1 isotype.
    Caldas IS; Diniz LF; Guedes PMDM; Nascimento ÁFDSD; Galvão LMDC; Lima WG; Caldas S; Bahia MT
    Acta Trop; 2017 Mar; 167():40-49. PubMed ID: 27993495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
    Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.